BackIntra-Cellular Therapies Overview
Intra-Cellular Therapies Inc

Intra-Cellular Therapies PEG Ratio

Intra-Cellular Therapies (ITCI) has a PEG ratio of 447.61, above the Healthcare sector average of 11.64.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

447.61

PEG Ratio

447.61

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

Average PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Intra-Cellular Therapies (ITCI) FAQ

As of the most recent data, ITCI shows a PEG ratio of 447.61. That is above the Healthcare sector average of 11.64. Scroll down for historical charts and peer comparison views.

The Healthcare sector average PEG ratio is about 11.64. Intra-Cellular Therapies is at 447.61, which is higher that average. That is roughly 3745.1% above the sector mean. Use the comparison chart on this page to see how ITCI stacks up against individual peers as well.

Investors watch ITCI's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Intra-Cellular Therapies's latest reading is 447.61. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this peg ratio page, Stockcircle has Intra-Cellular Therapies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 447.61) with ownership activity and broader fundamentals.

The Healthcare average PEG ratio is about 11.64, while ITCI is at 447.61. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.